Beta-thymosins and interstitial lung disease: Study of a scleroderma cohort with a one-year follow-up

Maria De Santis, Rosanna Inzitari, Silvia L. Bosello, Giusy Peluso, Chiara Fanali, Federica Iavarone, Gaetano Zizzo, Mario Bocci, Tiziana Cabras, Irene Messana, Leo Fuso, Francesco Varone, Gabriella Pagliari, Massimo Castagnola, Gianfranco Ferraccioli

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Background: Beta-thymosins play roles in cytoskeleton rearrangement, angiogenesis, fibrosis and reparative process, thus suggesting a possible involvement in the pathogenesis of systemic sclerosis. The aim of the study was to investigate the presence of thymosins beta4, beta4 sulfoxide, and beta10 in bronchoalveolar lavage fluid of scleroderma patients with interstitial lung disease and the relation of these factors with pulmonary functional and radiological parameters. Methods: Beta-thymosins concentrations were determined by Reverse Phase-High Performance Liquid Chromatography-Electrospray-Mass Spectrometry in the bronchoalveolar lavage fluid of 46 scleroderma patients with lung involvement and of 15 controls. Results: Thymosin beta4, beta4 sulfoxide, and beta10 were detectable in bronchoalveolar lavage fluid of patients and controls. Thymosin beta4 levels were significantly higher in scleroderma patients than in controls. In addition, analyzing the progression of scleroderma lung disease at one-year follow-up, we have found that higher thymosin beta4 levels seem to have a protective role against lung tissue damage. Thymosin beta4 sulfoxide levels were higher in the smokers and in the scleroderma patients with alveolitis. Conclusions: We describe for the first time beta-thymosins in bronchoalveolar lavage fluid and their possible involvement in the pathogenesis of scleroderma lung disease. Thymosin beta4 seems to have a protective role against lung tissue damage, while its oxidation product mirrors an alveolar inflammatory status.

Original languageEnglish
Pages (from-to)22
Number of pages1
JournalRespiratory Research
DOIs
Publication statusAccepted/In press - Feb 11 2011

Fingerprint

Thymosin
sulfoxide
Interstitial Lung Diseases
Bronchoalveolar Lavage Fluid
Lung
Lung Diseases
Systemic Scleroderma
Cytoskeleton
thymosin beta(4)
Mass Spectrometry
Fibrosis
High Pressure Liquid Chromatography

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

De Santis, M., Inzitari, R., Bosello, S. L., Peluso, G., Fanali, C., Iavarone, F., ... Ferraccioli, G. (Accepted/In press). Beta-thymosins and interstitial lung disease: Study of a scleroderma cohort with a one-year follow-up. Respiratory Research, 22. https://doi.org/10.1186/1465-9921-12-22

Beta-thymosins and interstitial lung disease : Study of a scleroderma cohort with a one-year follow-up. / De Santis, Maria; Inzitari, Rosanna; Bosello, Silvia L.; Peluso, Giusy; Fanali, Chiara; Iavarone, Federica; Zizzo, Gaetano; Bocci, Mario; Cabras, Tiziana; Messana, Irene; Fuso, Leo; Varone, Francesco; Pagliari, Gabriella; Castagnola, Massimo; Ferraccioli, Gianfranco.

In: Respiratory Research, 11.02.2011, p. 22.

Research output: Contribution to journalArticle

De Santis, M, Inzitari, R, Bosello, SL, Peluso, G, Fanali, C, Iavarone, F, Zizzo, G, Bocci, M, Cabras, T, Messana, I, Fuso, L, Varone, F, Pagliari, G, Castagnola, M & Ferraccioli, G 2011, 'Beta-thymosins and interstitial lung disease: Study of a scleroderma cohort with a one-year follow-up', Respiratory Research, pp. 22. https://doi.org/10.1186/1465-9921-12-22
De Santis, Maria ; Inzitari, Rosanna ; Bosello, Silvia L. ; Peluso, Giusy ; Fanali, Chiara ; Iavarone, Federica ; Zizzo, Gaetano ; Bocci, Mario ; Cabras, Tiziana ; Messana, Irene ; Fuso, Leo ; Varone, Francesco ; Pagliari, Gabriella ; Castagnola, Massimo ; Ferraccioli, Gianfranco. / Beta-thymosins and interstitial lung disease : Study of a scleroderma cohort with a one-year follow-up. In: Respiratory Research. 2011 ; pp. 22.
@article{02dfe73913b74d928b0a6a7d0fc52ab7,
title = "Beta-thymosins and interstitial lung disease: Study of a scleroderma cohort with a one-year follow-up",
abstract = "Background: Beta-thymosins play roles in cytoskeleton rearrangement, angiogenesis, fibrosis and reparative process, thus suggesting a possible involvement in the pathogenesis of systemic sclerosis. The aim of the study was to investigate the presence of thymosins beta4, beta4 sulfoxide, and beta10 in bronchoalveolar lavage fluid of scleroderma patients with interstitial lung disease and the relation of these factors with pulmonary functional and radiological parameters. Methods: Beta-thymosins concentrations were determined by Reverse Phase-High Performance Liquid Chromatography-Electrospray-Mass Spectrometry in the bronchoalveolar lavage fluid of 46 scleroderma patients with lung involvement and of 15 controls. Results: Thymosin beta4, beta4 sulfoxide, and beta10 were detectable in bronchoalveolar lavage fluid of patients and controls. Thymosin beta4 levels were significantly higher in scleroderma patients than in controls. In addition, analyzing the progression of scleroderma lung disease at one-year follow-up, we have found that higher thymosin beta4 levels seem to have a protective role against lung tissue damage. Thymosin beta4 sulfoxide levels were higher in the smokers and in the scleroderma patients with alveolitis. Conclusions: We describe for the first time beta-thymosins in bronchoalveolar lavage fluid and their possible involvement in the pathogenesis of scleroderma lung disease. Thymosin beta4 seems to have a protective role against lung tissue damage, while its oxidation product mirrors an alveolar inflammatory status.",
author = "{De Santis}, Maria and Rosanna Inzitari and Bosello, {Silvia L.} and Giusy Peluso and Chiara Fanali and Federica Iavarone and Gaetano Zizzo and Mario Bocci and Tiziana Cabras and Irene Messana and Leo Fuso and Francesco Varone and Gabriella Pagliari and Massimo Castagnola and Gianfranco Ferraccioli",
year = "2011",
month = "2",
day = "11",
doi = "10.1186/1465-9921-12-22",
language = "English",
pages = "22",
journal = "Respiratory Research",
issn = "1465-9921",
publisher = "BioMed Central",

}

TY - JOUR

T1 - Beta-thymosins and interstitial lung disease

T2 - Study of a scleroderma cohort with a one-year follow-up

AU - De Santis, Maria

AU - Inzitari, Rosanna

AU - Bosello, Silvia L.

AU - Peluso, Giusy

AU - Fanali, Chiara

AU - Iavarone, Federica

AU - Zizzo, Gaetano

AU - Bocci, Mario

AU - Cabras, Tiziana

AU - Messana, Irene

AU - Fuso, Leo

AU - Varone, Francesco

AU - Pagliari, Gabriella

AU - Castagnola, Massimo

AU - Ferraccioli, Gianfranco

PY - 2011/2/11

Y1 - 2011/2/11

N2 - Background: Beta-thymosins play roles in cytoskeleton rearrangement, angiogenesis, fibrosis and reparative process, thus suggesting a possible involvement in the pathogenesis of systemic sclerosis. The aim of the study was to investigate the presence of thymosins beta4, beta4 sulfoxide, and beta10 in bronchoalveolar lavage fluid of scleroderma patients with interstitial lung disease and the relation of these factors with pulmonary functional and radiological parameters. Methods: Beta-thymosins concentrations were determined by Reverse Phase-High Performance Liquid Chromatography-Electrospray-Mass Spectrometry in the bronchoalveolar lavage fluid of 46 scleroderma patients with lung involvement and of 15 controls. Results: Thymosin beta4, beta4 sulfoxide, and beta10 were detectable in bronchoalveolar lavage fluid of patients and controls. Thymosin beta4 levels were significantly higher in scleroderma patients than in controls. In addition, analyzing the progression of scleroderma lung disease at one-year follow-up, we have found that higher thymosin beta4 levels seem to have a protective role against lung tissue damage. Thymosin beta4 sulfoxide levels were higher in the smokers and in the scleroderma patients with alveolitis. Conclusions: We describe for the first time beta-thymosins in bronchoalveolar lavage fluid and their possible involvement in the pathogenesis of scleroderma lung disease. Thymosin beta4 seems to have a protective role against lung tissue damage, while its oxidation product mirrors an alveolar inflammatory status.

AB - Background: Beta-thymosins play roles in cytoskeleton rearrangement, angiogenesis, fibrosis and reparative process, thus suggesting a possible involvement in the pathogenesis of systemic sclerosis. The aim of the study was to investigate the presence of thymosins beta4, beta4 sulfoxide, and beta10 in bronchoalveolar lavage fluid of scleroderma patients with interstitial lung disease and the relation of these factors with pulmonary functional and radiological parameters. Methods: Beta-thymosins concentrations were determined by Reverse Phase-High Performance Liquid Chromatography-Electrospray-Mass Spectrometry in the bronchoalveolar lavage fluid of 46 scleroderma patients with lung involvement and of 15 controls. Results: Thymosin beta4, beta4 sulfoxide, and beta10 were detectable in bronchoalveolar lavage fluid of patients and controls. Thymosin beta4 levels were significantly higher in scleroderma patients than in controls. In addition, analyzing the progression of scleroderma lung disease at one-year follow-up, we have found that higher thymosin beta4 levels seem to have a protective role against lung tissue damage. Thymosin beta4 sulfoxide levels were higher in the smokers and in the scleroderma patients with alveolitis. Conclusions: We describe for the first time beta-thymosins in bronchoalveolar lavage fluid and their possible involvement in the pathogenesis of scleroderma lung disease. Thymosin beta4 seems to have a protective role against lung tissue damage, while its oxidation product mirrors an alveolar inflammatory status.

UR - http://www.scopus.com/inward/record.url?scp=79751537902&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79751537902&partnerID=8YFLogxK

U2 - 10.1186/1465-9921-12-22

DO - 10.1186/1465-9921-12-22

M3 - Article

C2 - 21314931

AN - SCOPUS:79751537902

SP - 22

JO - Respiratory Research

JF - Respiratory Research

SN - 1465-9921

ER -